FG Trade/E+ via Getty Images
An sNDA filed by BioMarin Pharmaceutical (BMRN) seeking full approval of its achondroplasia treatment Voxzogo (vosoritide) has been accepted by the US FDA.
The action date is Feb. 28, 2027.
The application is supported by three long-term trials.
The therapy was granted accelerated approval in 2021.
The German government made it clear today that any vote on a boycott or toughening of trade terms with...
SK Hynix's US-listed shares fell nearly 8% in early trade on Monday, giving up part of Friday’s strong debut gains...
The United States and Iran each asserted Monday they controlled the Strait of Hormuz after a weekend of attacks stretching across the wider Middle...
Bitcoin (BTC-USD) opened at $63,745.37 on Monday, July 13, 2026, 0.2% lower than Sunday's opening price. As of 9:30 a.m. ET...
XRP (CRYPTO: XRP) trades around $1.10 today. That's down close to 50% over the last six months despite billions of...
Israeli software company Redis is embarking on a major round of layoffs in Israel. "Globes" has learned that the...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
